He talks about HIV resistance in the context of pre-exposure prophylaxis use, how common it is, and how PrEP might influence subsequent therapies.
Which of the following are characteristics of primary HIV infection in users of pre-exposure prophylaxis?
In this Test Your Knowledge quiz, Diana Finkel, DO, poses a clinical scenario and asks you how you would manage this patient who is at high risk for HIV and is attending college for the first time.
A recent study investigated whether an increase in access to PrEP would increase the likelihood of adherence to the medication. Do you think this would work in your practice?
For the first time, the US Preventive Services Task Force has made recommendations for all at-risk populations of HIV infection to receive PrEP therapy. To see which populations are included in this recommendation, read more.
A new study presented at AIDS 2018 shed light on the incidence of hepatitis C virus re-infection among men who have sex with men and were using pre-exposure prophylaxis. The findings may lead to better disease management.
Dr Hyman Scott from the UCSF-Glastone Center for AIDS Research discusses pre-exposure prophylaxis (PrEP) therapy, its indications, and clinical data surrounding its use.
A new study of more than 27,000 MSM has indicated that increased HIV PrEP use has unexpectedly led to decreased condom use among men not using PrEP. Consultant360 spoke with lead study author Martin Holt, PhD, about these findings and what they mean for STI prevention in this patient population.